Background Catheter ablation is less successful for persistent atrial fibrillation than for
paroxysmal atrial fibrillation. Guidelines suggest that adjuvant substrate modification in …

Background Current guidelines recommend pulmonary-vein isolation by means of catheter
ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency …

Background Dabigatran etexilate, a new thrombin inhibitor, has been shown to be
comparable to warfarin in patients with atrial fibrillation (AF). However, there is a limited …

Background—Contact force (CF) is a major determinant of lesion size and transmurality and
has the potential to improve efficacy of atrial fibrillation ablation. This study sought to …

Aims The primary safety and efficacy endpoints of the randomized FIRE AND ICE trial have
recently demonstrated non-inferiority of cryoballoon vs. radiofrequency current (RFC) …

Aim Cryoballoon ablation (Cryoballoon) has emerged as a new alternative for the treatment
of symptomatic drug-refractory atrial fibrillation (AF). Whether the results of Cryoballoon are …

Real‐Time Contact Force Sensing for Pulmonary Vein Isolation Introduction The additional
benefit of contact force (CF) technology during pulmonary vein isolation (PVI) for paroxysmal …

Aims Whether pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) using
contact force (CF)-guided radiofrequency (RF) or second-generation cryoballoon (CB) …

Background: The FIRE AND ICE trial assessed efficacy and safety of pulmonary vein (PV)
isolation using cryoballoon versus radiofrequency current (RFC) ablation in patients with …

Aims In the setting of paroxysmal atrial fibrillation (AF), there are no available data
comparing the mid-term outcome of patients undergoing pulmonary vein isolation (PVI) …